CESCA THERAPEUTICS INC. Uncategorized Contracts & Agreements
30 Contracts & Agreements
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 30, 2023)
- Amendment to the Amended and Restated Certificate of Incorporation of ThermoGenesis Holdings, Inc (Filed With SEC on December 20, 2022)
- Engagement Letter Amendment, dated October 14, 2022, between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on October 17, 2022)
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on May 27, 2022)
- Engagement Letter, dated as of March 8, 2022, between ThermoGenesis Holding, Inc. and H.C. Wainright & Co., LLC (Filed With SEC on April 29, 2022)
- Amendment No. 2 to At the Market Offering Agreement, dated February 3, 2022, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on February 3, 2022)
- Amendment No. 1 to At The Market Offering Agreement, dated May 19, 2020, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on May 20, 2020)
- Engagement Agreement, dated as of March 24, 2020, by and between ThermoGenesis Holdings, Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 27, 2020)
- Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended (Filed With SEC on March 24, 2020)
- Stockholders Agreement, dated November 22, 2019, among ThermoGenesis Holdings, Inc., Healthbanks Biotech (USA) Inc. and ImmuneCyte Life Sciences Inc (Filed With SEC on November 27, 2019)
- Amended and Restated Certificate of Incorporation of CARTXpress Bio, Inc (Filed With SEC on January 4, 2019)
- Right of First Refusal and Co-Sale Agreement, dated January 1, 2019, among CARTXpress Bio, Inc., ThermoGenesis Corp., Bay City Capital Fund V, L.P., and Bay City Capital Fund V... (Filed With SEC on January 4, 2019)
- Engagement Letter, dated as of March 22, 2018, by and between Cesca Therapeutics Inc. and H.C. Wainwright & Co., LLC (Filed With SEC on March 28, 2018)
- International Distributor Agreement, dated August 21, 2017, between ThermoGenesis Corp. and Boyalife W.S.N (Filed With SEC on September 22, 2017)
- [*] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. (Filed With SEC on May 31, 2017)
- Form of Lock-up Agreement, dated July 15, 2013, by and among ThermoGenesis Corp., Mitchel Sivilotti, and Kenneth Harris (Filed With SEC on July 16, 2013)
- R E C I T A L S (Filed With SEC on October 24, 2012)
- R E C I T A L S (Filed With SEC on August 24, 2012)
- R E C I T A L S (Filed With SEC on March 28, 2012)
- R E C I T A L S (Filed With SEC on January 13, 2012)
- 2,250,000 Units (Filed With SEC on March 7, 2011)
- THERMOGENESIS CORP. (Filed With SEC on March 7, 2011)
- Current assets (Filed With SEC on February 11, 2011)
- R E C I T A L S (Filed With SEC on November 5, 2010)
- OPTION AGREEMENT (Filed With SEC on June 16, 2010)
- EXHIBIT 10.1(f) (Filed With SEC on September 11, 2008)
- EXHIBIT 10.1P (Filed With SEC on September 7, 2006)
- 8,000,000 Shares ThermoGenesis Corp. (Filed With SEC on January 31, 2006)
- EXHIBIT 10.1(o) (Filed With SEC on January 27, 2006)
- EXHIBIT 10.1(n) (Filed With SEC on January 27, 2006)
